17.200 0 (0%) 08-08 09:03 |
|
Open: | 17.200 |
High: | 17.200 |
Low: | 16.940 |
Pre. close: | 17.200 |
Volume: | 6,868 |
Avg. volume: | 12,686 |
MA (50): | 16.060 |
MA (200): | 16.104 |
Year high: | 20.450 |
Year low: | 13.620 |
Market cap: | 500(M) |
EPS: | 0.13 |
PE ratio: | 132.308 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Fri, 05 Aug 2022
Nuclear Medicine Market 2022 Emerging Technology Research Report by Key Players Cardinal Health, Inc., Medtronic, Minimally Invasive Therapies, Ion Beam Applications S.A – Shanghaiist - Shanghaiist
Fri, 05 Aug 2022
Philippines Radiotherapy Market – High Prevalence of Cancer is Expected To Increase Demand for its Treatment and Support The Market Growth | Elekta AB, Accuray Incorporated, Varian Medical Systems, Inc - Medgadget
Tue, 02 Aug 2022
IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy - GlobeNewswire
Mon, 25 Jul 2022
Proton Therapy Market to Surpass US$ 4494.0 Million with a CAGR of 16.7% from 2022 to 2028 | Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation - Digital Journal
Thu, 30 Jun 2022
IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy - GlobeNewswire
Wed, 01 Jun 2022
IBA signs Proteus®ONE contract with Baptist Health's Lynn - GlobeNewswire
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.